| Oleg Giren, CRNA | |
|
2701 N Decatur Rd, Decatur, GA 30033-5918 | |
| (678) 514-1991 | |
| (678) 514-1992 |
| Full Name | Oleg Giren |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 16 Years |
| Location | 2701 N Decatur Rd, Decatur, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356589592 | NPI | - | NPPES |
| 811658995A | Medicaid | GA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | RN167568 (Georgia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Gi Anesthesia Of Georgia Llc | 0446516769 | 95 |
News Archive
Veloxis Pharmaceuticals A/S today announced that enrolment has been completed in its pivotal LCP-Tacro Phase III study in de novo kidney transplant patients. The LCP-Tacro 3002 study is designed to demonstrate non-inferiority versus the gold standard therapy Prograf and has randomized over 540 patients at approximately 90 clinical sites around the world.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that data from its Phase 2 study of PV-10 for metastatic melanoma has been accepted for presentation at the 2010 American Society of Clinical Oncology (ASCO) Scientific Program to be held on June 4 – 8, 2010 in Chicago, Illinois.
Dr. Jinghui Zhang, an esteemed computational biologist at St. Jude Children's Research Hospital discusses her latest study and how technology such as cloud computing is changing the way that scientists carry out research.
VisEn Medical Inc., a leader in fluorescence in vivo imaging from research through medicine, announced the launch and availability of a new Fluorescence Molecular Tomography (FMT) imaging system - the FMT 1500, and an advanced version of its FMT 2500, the FMT 2500 LX.
New York Times bestselling authors David Zinczenko and Matt Goulding are out with the definitive list of the "20 Worst Drinks in America" as featured in the new book Drink This, Not That!—in stores now. The list highlights the country's most calorie-and sugar-laden drinks, everything from flavored waters and juice imposters to beers and margaritas.
› Verified 8 days ago
| Entity Name | American Anesthesiology Associates Of Georgia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528068673 PECOS PAC ID: 7618934779 Enrollment ID: O20041210000442 |
News Archive
Veloxis Pharmaceuticals A/S today announced that enrolment has been completed in its pivotal LCP-Tacro Phase III study in de novo kidney transplant patients. The LCP-Tacro 3002 study is designed to demonstrate non-inferiority versus the gold standard therapy Prograf and has randomized over 540 patients at approximately 90 clinical sites around the world.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that data from its Phase 2 study of PV-10 for metastatic melanoma has been accepted for presentation at the 2010 American Society of Clinical Oncology (ASCO) Scientific Program to be held on June 4 – 8, 2010 in Chicago, Illinois.
Dr. Jinghui Zhang, an esteemed computational biologist at St. Jude Children's Research Hospital discusses her latest study and how technology such as cloud computing is changing the way that scientists carry out research.
VisEn Medical Inc., a leader in fluorescence in vivo imaging from research through medicine, announced the launch and availability of a new Fluorescence Molecular Tomography (FMT) imaging system - the FMT 1500, and an advanced version of its FMT 2500, the FMT 2500 LX.
New York Times bestselling authors David Zinczenko and Matt Goulding are out with the definitive list of the "20 Worst Drinks in America" as featured in the new book Drink This, Not That!—in stores now. The list highlights the country's most calorie-and sugar-laden drinks, everything from flavored waters and juice imposters to beers and margaritas.
› Verified 8 days ago
| Entity Name | Gastroenterology Anesthesia Associates, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942563242 PECOS PAC ID: 3779730080 Enrollment ID: O20120821000929 |
News Archive
Veloxis Pharmaceuticals A/S today announced that enrolment has been completed in its pivotal LCP-Tacro Phase III study in de novo kidney transplant patients. The LCP-Tacro 3002 study is designed to demonstrate non-inferiority versus the gold standard therapy Prograf and has randomized over 540 patients at approximately 90 clinical sites around the world.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that data from its Phase 2 study of PV-10 for metastatic melanoma has been accepted for presentation at the 2010 American Society of Clinical Oncology (ASCO) Scientific Program to be held on June 4 – 8, 2010 in Chicago, Illinois.
Dr. Jinghui Zhang, an esteemed computational biologist at St. Jude Children's Research Hospital discusses her latest study and how technology such as cloud computing is changing the way that scientists carry out research.
VisEn Medical Inc., a leader in fluorescence in vivo imaging from research through medicine, announced the launch and availability of a new Fluorescence Molecular Tomography (FMT) imaging system - the FMT 1500, and an advanced version of its FMT 2500, the FMT 2500 LX.
New York Times bestselling authors David Zinczenko and Matt Goulding are out with the definitive list of the "20 Worst Drinks in America" as featured in the new book Drink This, Not That!—in stores now. The list highlights the country's most calorie-and sugar-laden drinks, everything from flavored waters and juice imposters to beers and margaritas.
› Verified 8 days ago
| Entity Name | Coastal Ambulatory Anesthesia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750753786 PECOS PAC ID: 1052613023 Enrollment ID: O20160107001775 |
News Archive
Veloxis Pharmaceuticals A/S today announced that enrolment has been completed in its pivotal LCP-Tacro Phase III study in de novo kidney transplant patients. The LCP-Tacro 3002 study is designed to demonstrate non-inferiority versus the gold standard therapy Prograf and has randomized over 540 patients at approximately 90 clinical sites around the world.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that data from its Phase 2 study of PV-10 for metastatic melanoma has been accepted for presentation at the 2010 American Society of Clinical Oncology (ASCO) Scientific Program to be held on June 4 – 8, 2010 in Chicago, Illinois.
Dr. Jinghui Zhang, an esteemed computational biologist at St. Jude Children's Research Hospital discusses her latest study and how technology such as cloud computing is changing the way that scientists carry out research.
VisEn Medical Inc., a leader in fluorescence in vivo imaging from research through medicine, announced the launch and availability of a new Fluorescence Molecular Tomography (FMT) imaging system - the FMT 1500, and an advanced version of its FMT 2500, the FMT 2500 LX.
New York Times bestselling authors David Zinczenko and Matt Goulding are out with the definitive list of the "20 Worst Drinks in America" as featured in the new book Drink This, Not That!—in stores now. The list highlights the country's most calorie-and sugar-laden drinks, everything from flavored waters and juice imposters to beers and margaritas.
› Verified 8 days ago
| Entity Name | Gi Anesthesia Of Georgia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326569187 PECOS PAC ID: 0446516769 Enrollment ID: O20171102000283 |
News Archive
Veloxis Pharmaceuticals A/S today announced that enrolment has been completed in its pivotal LCP-Tacro Phase III study in de novo kidney transplant patients. The LCP-Tacro 3002 study is designed to demonstrate non-inferiority versus the gold standard therapy Prograf and has randomized over 540 patients at approximately 90 clinical sites around the world.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that data from its Phase 2 study of PV-10 for metastatic melanoma has been accepted for presentation at the 2010 American Society of Clinical Oncology (ASCO) Scientific Program to be held on June 4 – 8, 2010 in Chicago, Illinois.
Dr. Jinghui Zhang, an esteemed computational biologist at St. Jude Children's Research Hospital discusses her latest study and how technology such as cloud computing is changing the way that scientists carry out research.
VisEn Medical Inc., a leader in fluorescence in vivo imaging from research through medicine, announced the launch and availability of a new Fluorescence Molecular Tomography (FMT) imaging system - the FMT 1500, and an advanced version of its FMT 2500, the FMT 2500 LX.
New York Times bestselling authors David Zinczenko and Matt Goulding are out with the definitive list of the "20 Worst Drinks in America" as featured in the new book Drink This, Not That!—in stores now. The list highlights the country's most calorie-and sugar-laden drinks, everything from flavored waters and juice imposters to beers and margaritas.
› Verified 8 days ago
| Entity Name | Anesthesia Dynamics Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073001012 PECOS PAC ID: 3779832530 Enrollment ID: O20200508002106 |
News Archive
Veloxis Pharmaceuticals A/S today announced that enrolment has been completed in its pivotal LCP-Tacro Phase III study in de novo kidney transplant patients. The LCP-Tacro 3002 study is designed to demonstrate non-inferiority versus the gold standard therapy Prograf and has randomized over 540 patients at approximately 90 clinical sites around the world.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that data from its Phase 2 study of PV-10 for metastatic melanoma has been accepted for presentation at the 2010 American Society of Clinical Oncology (ASCO) Scientific Program to be held on June 4 – 8, 2010 in Chicago, Illinois.
Dr. Jinghui Zhang, an esteemed computational biologist at St. Jude Children's Research Hospital discusses her latest study and how technology such as cloud computing is changing the way that scientists carry out research.
VisEn Medical Inc., a leader in fluorescence in vivo imaging from research through medicine, announced the launch and availability of a new Fluorescence Molecular Tomography (FMT) imaging system - the FMT 1500, and an advanced version of its FMT 2500, the FMT 2500 LX.
New York Times bestselling authors David Zinczenko and Matt Goulding are out with the definitive list of the "20 Worst Drinks in America" as featured in the new book Drink This, Not That!—in stores now. The list highlights the country's most calorie-and sugar-laden drinks, everything from flavored waters and juice imposters to beers and margaritas.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Oleg Giren, CRNA Po Box 551420, Fort Lauderdale, FL 33355-1420 Ph: (800) 243-3839 | Oleg Giren, CRNA 2701 N Decatur Rd, Decatur, GA 30033-5918 Ph: (678) 514-1991 |
News Archive
Veloxis Pharmaceuticals A/S today announced that enrolment has been completed in its pivotal LCP-Tacro Phase III study in de novo kidney transplant patients. The LCP-Tacro 3002 study is designed to demonstrate non-inferiority versus the gold standard therapy Prograf and has randomized over 540 patients at approximately 90 clinical sites around the world.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that data from its Phase 2 study of PV-10 for metastatic melanoma has been accepted for presentation at the 2010 American Society of Clinical Oncology (ASCO) Scientific Program to be held on June 4 – 8, 2010 in Chicago, Illinois.
Dr. Jinghui Zhang, an esteemed computational biologist at St. Jude Children's Research Hospital discusses her latest study and how technology such as cloud computing is changing the way that scientists carry out research.
VisEn Medical Inc., a leader in fluorescence in vivo imaging from research through medicine, announced the launch and availability of a new Fluorescence Molecular Tomography (FMT) imaging system - the FMT 1500, and an advanced version of its FMT 2500, the FMT 2500 LX.
New York Times bestselling authors David Zinczenko and Matt Goulding are out with the definitive list of the "20 Worst Drinks in America" as featured in the new book Drink This, Not That!—in stores now. The list highlights the country's most calorie-and sugar-laden drinks, everything from flavored waters and juice imposters to beers and margaritas.
› Verified 8 days ago
Samantha Wisner Valentini, RN Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2551 Wilson Woods Dr, Decatur, GA 30033 Phone: 770-757-0131 | |
Sara Stelling Jones, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1670 Clairmont Rd, Decatur, GA 30033 Phone: 404-321-6111 | |
Ron I Mcdaniel, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2701 N Decatur Rd, Decatur, GA 30033 Phone: 678-514-1991 Fax: 678-514-1992 | |
Dorothy Blue Wright, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1670 Clairmont Rd, Decatur, GA 30033 Phone: 404-321-6111 | |
Christine Hoefling, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 2701 N Decatur Rd, Decatur, GA 30033 Phone: 678-514-1991 Fax: 678-514-1992 | |
Natacha Simon-christie, DNP, CRNA Nurse Anesthetist - CR Medicare: May Accept Medicare Assignments Practice Location: 2701 N Decatur Rd, Decatur, GA 30033 Phone: 404-778-7408 Fax: 404-778-3238 |